Discussions List
0
LIKES
0
REPLIES
11
VIEWS
5
LIKES
1
REPLIES
298
VIEWS
7
LIKES
2
REPLIES
393
VIEWS
7
LIKES
2
REPLIES
486
VIEWS
18
LIKES
3
REPLIES
696
VIEWS
7
LIKES
1
REPLIES
446
VIEWS
8
LIKES
1
REPLIES
386
VIEWS
4
LIKES
1
REPLIES
352
VIEWS
6
LIKES
1
REPLIES
457
VIEWS
4
LIKES
1
REPLIES
702
VIEWS
6
LIKES
1
REPLIES
603
VIEWS
9
LIKES
1
REPLIES
780
VIEWS
6
LIKES
1
REPLIES
599
VIEWS
12
LIKES
1
REPLIES
651
VIEWS
5
LIKES
1
REPLIES
602
VIEWS
[WSRP26] Modeling dosing regimens with pharmacokinetic models for personalized glibenclamide therapy
5
LIKES
1
REPLIES
709
VIEWS
7
LIKES
1
REPLIES
601
VIEWS
10
LIKES
1
REPLIES
684
VIEWS
8
LIKES
2
REPLIES
721
VIEWS
6
LIKES
1
REPLIES
682
VIEWS